Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Cisplatinum re-challenge overcame carboplatin hypersensitivity
November 10th, 2005
Cisplatinum re-challenge could be used to overcome carboplatin hypersensitivity in patients with relapsed ovarian cancer. According to recent research from Germany, "Hypersensitivity reactions have been reported as limiting side effect in patients re-exposed to carboplatin for relapsed gynecologic malignancy. This study analyzed the incidence, clinical features, management, and outcome of carboplatin-associated hypersensitivity reactions." "We performed a retrospective study and analyzed medical records of all gynecological cancer patients treated with carboplatin in our institution from 2000 to 2003. No hypersensitivity reactions were observed in...
Source: Women's Health Weekly (2005-11-10)
|
